The overall bias of XRPUSD is bullish. We could see that price has broken and retested a major resistance zone which is also inline with the retest of the 50 EMA. There could be a possible price continuation to the upside. The rsi and macd indicator are above the centreline which adds to the confluence of a possible push of price to the next resistance zone.
Pfizer Inc is expected to provide around 10 million courses of its highly effective COVID-19 antiviral treatment Paxlovid to low- and middle-income countries this year, according to an official with the Global Fund, a healthcare NGO working to buy the pills from the drugmaker.
From the overview of price, we could see that the trend is bearish. Price seems to be retesting the resistance zone between 4455 and 4399 which also have a confluence with the 50 EMA. The RSI and MACD are below the centreline which shows that there could be a possible move of price to the downside
From the overview of price in EURNZD, we could see that the overall trend has been bearish. Price has gotten to the resistance level between 1.63387 and 1.62858 and there could be a possible pullback to the support zone. We could see that the RSI is in the oversold level which shows that there could be a reversal soon.